Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × UNKNOWN × pegylated granulocyte colony-stimulating factor × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

OTHER 8 INDUSTRY 4 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

toripalimab 1 pegylated granulocyte colony-stimulating factor 1 Idarubicin 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Growth Hormone 1 Cytarabine 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02953730 2016-11-03

The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents

ChineseAMS

Phase 4 Completed

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡